David Rubinsztein

Mice with an OPMD-like disease treated with cystamine showed improved strength and muscle function and fewer cellular abnormalities

posted on June 9, 2010 - 12:43pm
Scientists in the United Kingdom have found that mice carrying a genetic mutation that causes oculpharyngeal muscular dystrophy (OPMD) in humans and showing a disease resembling human OPMD benefited from treatment with a chemical called cystamine, provided in their drinking water. About the new findings David Rubinsztein and colleagues at the University of Cambridge announced their findings June...

New content is being added every day. Please check back again.